Oragenics, Inc. to Present Overview of Lantibiotics Pipeline at the Annual Military Health System Research Symposium

UF startup Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, announced it will be presenting a talk titled “Lantibiotics, a Novel Class of Antibiotics in the Pharmacopeia,” which will be part of a session dedicated to novel antimicrobial developments to counter multidrug-resistant bacterial infections in military personnel. This talk will be presented at the annual Military Health System Research Symposium (MHSRS).